Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that the company’s management team will provide a company overview at the Deutsche Bank 41st Annual Healthcare Conference on Thursday, May 5, 2016 at 2:10 p.m. ET / 11:10 a.m. PT in Boston, Massachusetts. The event will be webcast live and may be accessed under “Events and Presentations” on the Investors page of Anacor’s website at www.anacor.com. A replay will also be available for three months following the presentation.

About Anacor Pharmaceuticals

Anacor is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. Anacor’s first approved product, KERYDIN® (tavaborole) topical solution, 5%, is an oxaborole antifungal approved by the U.S. Food and Drug Administration in July 2014 for the topical treatment of onychomycosis of the toenails. In July 2014, Anacor entered into an exclusive agreement with Sandoz Inc., a Novartis company, pursuant to which PharmaDerm, the branded dermatology division of Sandoz, distributes and commercializes KERYDIN in the United States. In September 2014, PharmaDerm launched KERYDIN. Anacor’s lead product development candidate is crisaborole topical ointment, 2%, a novel non-steroidal topical anti-inflammatory PDE-4 inhibitor in development for the potential treatment of mild-to-moderate atopic dermatitis and psoriasis. Beyond KERYDIN and crisaborole, Anacor has discovered three investigational compounds that it has out-licensed for further development. Anacor also has a pipeline of other internally discovered topical and systemic boron-based compounds in early stages of research and development. For more information, visit www.anacor.com.

Anacor Pharmaceuticals, Inc.DeDe Sheel, 650-543-7575Senior Director, Investor Relations and Corporate Communications

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Anacor Pharmaceuticals, Inc. Charts.
Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Anacor Pharmaceuticals, Inc. Charts.